Axel Grothey1, Daniel J Sargent. Show Affiliations » 1. Mayo Clinic College of Medicine, Department of Medical Oncology, Rochester, MN, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useColonic Neoplasms/drug therapyColonic Neoplasms/mortalityColonic Neoplasms/pathologyDose-Response Relationship, DrugDrug Administration ScheduleDrug ApprovalFemaleFluorouracil/therapeutic useHumansLeucovorin/therapeutic useMaleMaximum Tolerated DoseNeoplasm Invasiveness/pathologyNeoplasm StagingOrganoplatinum Compounds/therapeutic useOxaliplatinPrognosisRandomized Controlled Trials as TopicSurvival AnalysisTreatment OutcomeUnited StatesUnited States Food and Drug Administration
Substances： See more » Organoplatinum CompoundsOxaliplatinLeucovorinFluorouracil
Year: 2005 PMID： 15908645 DOI： 10.1200/JCO.2005.11.691
Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544